| Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis E Tacconelli, E Carrara, A Savoldi, S Harbarth, M Mendelson, DL Monnet, ... The Lancet infectious diseases 18 (3), 318-327, 2018 | 5661 | 2018 |
| Antibiotic resistance—the need for global solutions R Laxminarayan, A Duse, C Wattal, AKM Zaidi, HFL Wertheim, ... The Lancet infectious diseases 13 (12), 1057-1098, 2013 | 5230 | 2013 |
| Disease control priorities in developing countries DT Jamison, JG Breman, AR Measham, G Alleyne, M Claeson, DB Evans, ... World Bank Publications, 2006 | 4305* | 2006 |
| Global trends in antimicrobial use in food animals TP Van Boeckel, C Brower, M Gilbert, BT Grenfell, SA Levin, TP Robinson, ... Proceedings of the National Academy of Sciences 112 (18), 5649-5654, 2015 | 4020 | 2015 |
| Global increase and geographic convergence in antibiotic consumption between 2000 and 2015 EY Klein, TP Van Boeckel, EM Martinez, S Pant, S Gandra, SA Levin, ... Proceedings of the National Academy of Sciences 115 (15), E3463-E3470, 2018 | 3162 | 2018 |
| Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data TP Van Boeckel, S Gandra, A Ashok, Q Caudron, BT Grenfell, SA Levin, ... The Lancet infectious diseases 14 (8), 742-750, 2014 | 2647 | 2014 |
| Access to effective antimicrobials: a worldwide challenge R Laxminarayan, P Matsoso, S Pant, C Brower, JA Røttingen, K Klugman, ... The Lancet 387 (10014), 168-175, 2016 | 1402 | 2016 |
| The global threat of antimicrobial resistance: science for intervention I Roca, M Akova, F Baquero, J Carlet, M Cavaleri, S Coenen, J Cohen, ... New microbes and new infections 6, 22-29, 2015 | 1364 | 2015 |
| Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999–2005 E Klein, DL Smith, R Laxminarayan Emerging infectious diseases 13 (12), 1840, 2007 | 1350 | 2007 |
| Antimicrobial resistance in developing countries. Part I: recent trends and current status IN Okeke, R Laxminarayan, ZA Bhutta, AG Duse, P Jenkins, TF O'Brien, ... The Lancet infectious diseases 5 (8), 481-493, 2005 | 1235 | 2005 |
| Non-prescription antimicrobial use worldwide: a systematic review DJ Morgan, IN Okeke, R Laxminarayan, EN Perencevich, S Weisenberg The Lancet infectious diseases 11 (9), 692-701, 2011 | 1103 | 2011 |
| Global trends in antimicrobial resistance in animals in low-and middle-income countries TP Van Boeckel, J Pires, R Silvester, C Zhao, J Song, NG Criscuolo, ... Science 365 (6459), eaaw1944, 2019 | 954 | 2019 |
| Addressing the burden of mental, neurological, and substance use disorders: key messages from Disease Control Priorities V Patel, D Chisholm, R Parikh, FJ Charlson, L Degenhardt, T Dua, ... The Lancet 387 (10028), 1672-1685, 2016 | 923 | 2016 |
| Antibiotic resistance is the quintessential One Health issue TP Robinson, DP Bu, J Carrique-Mas, EM Fèvre, M Gilbert, D Grace, ... Transactions of the Royal Society of Tropical Medicine and Hygiene 110 (7 …, 2016 | 812 | 2016 |
| Reducing antimicrobial use in food animals TP Van Boeckel, EE Glennon, D Chen, M Gilbert, TP Robinson, ... Science 357 (6358), 1350-1352, 2017 | 741 | 2017 |
| Anthropological and socioeconomic factors contributing to global antimicrobial resistance: a univariate and multivariable analysis P Collignon, JJ Beggs, TR Walsh, S Gandra, R Laxminarayan The Lancet Planetary Health 2 (9), e398-e405, 2018 | 677 | 2018 |
| Vital signs: carbapenem-resistant Enterobacteriaceae JT Jacob, E Klein, R Laxminarayan, Z Beldavs, R Lynfield, AJ Kallen, ... Morbidity and mortality weekly report 62 (9), 165, 2013 | 628 | 2013 |
| Antibiotic resistance in India: drivers and opportunities for action R Laxminarayan, RR Chaudhury PLoS medicine 13 (3), e1001974, 2016 | 599 | 2016 |
| Helminth infections: soil-transmitted helminth infections and schistosomiasis PJ Hotez, DAP Bundy, K Beegle, S Brooker, L Drake, N de Silva, ... Oxford University Press and World Bank, 2006 | 567 | 2006 |
| Malaria: current status of control, diagnosis, treatment, and a proposed agenda for research and development PJ Guerin, P Olliaro, F Nosten, P Druilhe, R Laxminarayan, F Binka, ... The Lancet infectious diseases 2 (9), 564-573, 2002 | 560 | 2002 |
Eili KleinJohns Hopkins UniversityEmail verificata su jhu.edu